Fears over a medical gold rush in cancer drug race https://t.co/eijGXVoFPp via @FT
— The Propell Group (@ThePropellGroup) July 3, 2017
#healthtech
Fears over a medical gold rush in cancer drug race https://t.co/eijGXVoFPp via @FT
— The Propell Group (@ThePropellGroup) July 3, 2017
#healthtech